Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Proderma
- Development stage
- Preclinical
- Lead developer
- Biohellenika
- Modality
- Stem Cell Therapies → Cell Therapies, Hydrogel Systems → Drug Delivery Systems
- Administration
- Topical
01
Overview
**Proderma** is a preclinical regenerative wound-healing program coordinated by Biohellenika that is developing antimicrobial polymeric hydrogel skin-regeneration patches supplemented with extracellular-matrix components, bioactive peptides, and human adipose stromal cells. The patch is intended to support local tissue repair while providing inherent antimicrobial activity through material chemistry and surface topography, potentially avoiding the need for added antimicrobial drugs that could impair skin regeneration. ([biohellenika.gr](https://www.biohellenika.gr/profil/programmata/proderma))
- Other names
- Proderma
Beyond the preview
Go deeper on Proderma.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Proderma.